Christoph Tang is currently Professor of Cellular Pathology at the Sir William Dunn School of Pathology, University of Oxford and a Wellcome Trust Senior Investigator. He spent two years working in the Gambia as a clinical officer, and was awarded a PhD at the Royal Postgraduate Medical School working on the fungal pathogen, Aspergillus fumigatus. He was then appointed as a Clinical Lecturer in the Nuffield Department of Medicine Oxford then received an MRC Clinician Scientist Award which included a year's fellowship at the Center for Vaccine Development at the University of Maryland. He was appointed to a Professorship in Infectious Diseases at Imperial College London, then moved to his current position in 2010. His group studies human specific bacterial pathogens which are specialized microbes that are adapted to their human host. The group seeks to understand the basis of how these pathogens colonise specific niches in the body, evade elimination by the immune system, and cause disease. The group studies Neisseria spp., which are leading causes of bacterial meningitis and gonorrhoea, and enteric pathogens, such as Shigella spp. Work from the group has been included in vaccines which are in clinical development with the Serum Institute of India and GSK.